A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: gemcitabine|DRUG: paclitaxel|DRUG: bevacizumab
Sponsor: Eli Lilly and Company
Collaborators: Genentech, Inc.